Company profile: TherOx
1.1 - Company Overview
Company description
- Provider of SuperSaturated Oxygen (SSO2) Therapy, a catheter-based treatment delivering hyperoxemic oxygen to the ischemic myocardium following PCI to reduce infarct size, and the TherOx DownStream System for preparation and delivery of SSO2 to targeted ischemic regions of the heart immediately after revascularization.
Products and services
- TherOx DownStream System: A post-PCI device indicated to prepare and deliver SuperSaturated Oxygen Therapy to targeted ischemic myocardial regions immediately after revascularization by percutaneous coronary intervention
- SuperSaturated Oxygen (SSO2) Therapy: A catheter-based therapy engineered to reduce infarct size by delivering hyperoxemic oxygen directly to the ischemic myocardium following percutaneous coronary intervention
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TherOx
Avive
HQ: United States
Website
- Description: Provider of an automated external defibrillator for emergency use that delivers electrical therapy to stop arrhythmias and restore normal heart rhythm, and software solutions to support the use and management of the device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avive company profile →
Axovan
HQ: Switzerland
Website
- Description: Provider of drug development specializing in G protein-coupled receptors, based in Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axovan company profile →
4C Medical
HQ: United States
Website
- Description: Provider of minimally invasive therapies for structural heart disease, including AltaValve, a transcatheter mitral valve replacement device designed to treat mitral regurgitation by positioning above the native valve, preserving cardiac structures, and accommodating complex anatomies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4C Medical company profile →
CardioMech
HQ: Norway
Website
- Description: Provider of transcatheter devices for structural heart disease, offering an alternative to cardiac surgery for mitral valve chordal repair. Its catheter-based therapy places artificial chords to reduce or eliminate mitral regurgitation without open-heart surgery, giving surgeons new therapeutic options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioMech company profile →
Luminetx
HQ: United States
Website
- Description: Provider of bioscience technologies, including the VeinViewer Imaging System that images vascular structures, allowing healthcare professionals to clearly see accessible vasculature in real time on the skin surface.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminetx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TherOx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TherOx
2.2 - Growth funds investing in similar companies to TherOx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TherOx
4.2 - Public trading comparable groups for TherOx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →